|
Statement of Need
Urology experts generally agree that the urological patient will benefit greatly if the treatment provided is the result of a combined effort among the specialists involved in patient care. The collaboration of experts from various fields is thus necessary to improve urological research and enhance medical practice worldwide and to close the practice gap found among current treatment protocols. The 2009 Future Directions in Urology Symposium (FDUS) brought together leading urologists, radiologists, radiation oncologists, and medical oncologists to provide a forum for
sharing knowledge and experience with
the objective of facilitating multidisciplinary
approaches that aim to optimize
disease prevention and diagnostic
therapeutic interventions. A four-day
symposium was held, featuring state-ofthe-
art lectures, case reports, a review of
clinical trials, and treatment guideline
analysis. Group discussion assisted in
improving competence and knowledge
and addressed four Institute of Medicine
(IOM) Universal Physician competencies:
to provide patient-centered
care, to work in interdisciplinary teams,
to employ evidence-based practice, and
to apply quality improvement.
|
|
Read more...
|
|
|
Statement of Need
Genitourinary (GU) cancer refers to abnormal cell growth leading to the formation of tumors in the genital and/or urinary organs. Most genitourinary cancers occur in the prostate (in men), kidneys, or bladder. The American Cancer Society’s 2009 report estimates that 37%, or approximately 283,468 of the estimated 766,130 cases of cancer in men diagnosed in the US will involve a type of genitourinary cancer. Among cancer deaths in men, genitourinary cancers will account for nearly 20% (55,582) of the expected 292,540 deaths. This activity will review both the need for improved tumor markers to diagnose and prevent GU cancers, and ongoing research in treatment models for the various types GU cancers.
|
|
Read more...
|
|
|